James B. Hawkins
CIK: 0000898243
James B. Hawkins's purchase track record
How the stock did after each of James B. Hawkins's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
5
of 5 since March 19, 2025
Stock higher 6 months later
40%
3 months: 40%
Median 6-month return
-35.8%
3 months: -0.3%
Beat the S&P 500
20%
median -46.8% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/10/2026 | AEYE | $220K | +12.3% | +32.2% | +13.2% |
| 11/20/2025 | AEYE | $45K | -40.9% | -35.8% | +13.9% |
| 11/11/2025 | AEYE | $218K | -39.4% | -38.7% | +8.1% |
| 8/18/2025 | AEYE | $88K | +3.6% | -40.8% | +6.1% |
| 3/19/2025 | AEYE | $205K | -0.3% | +12.3% | +16.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
OSI Systems Faces Price Target Cut After 103% Surge. OSI Systems stock climbed 103% recently, prompting a review of its valuation. Oppenheimer still rates the stock as outperform but lowered its target to $265 from higher levels. The move reflects a more cautious view after the sharp rally. Analysts see the stock trading near its 52‑week high, adding pressure on the new target.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
iRadimed Gets Needham Hold Rating and Conference Participation. Needham initiated coverage on iRadimed with a Hold rating, while the company announced it will speak at the ROTH Healthcare Opportunities Conference. These developments add analyst visibility to the stock, which is currently trading near its 52-week high. The new coverage provides a fresh perspective on the company's position in the medical imaging sector.
Transaction History
| AEYE | ▲ Buy | Grant | 1,000 | $0 | 10/1/2026 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 90 | $20K | 8/20/2026 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 144 | $33K | 8/14/2026 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 170 | $37K | 7/28/2026 | View on chart |
| OSIS | ▲ Buy | Grant | 924 | $200K | 7/20/2026 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 231 | $51K | 7/6/2026 | View on chart |
| AEYE | ▲ Buy | Grant | 1,000 | $0 | 7/1/2026 | View on chart |
| AEYE | ▲ Buy | Grant | 8,500 | $0 | 6/22/2026 | View on chart |
| AEYE | ▲ Buy | Grant | 667 | $0 | 4/1/2026 | View on chart |
| AEYE | ▲ Buy | Open Market | 11,000 | $62K | 3/12/2026 | View on chart |
| AEYE | ▲ Buy | Open Market | 13,000 | $75K | 3/11/2026 | View on chart |
| AEYE | ▲ Buy | Open Market | 14,000 | $83K | 3/10/2026 | View on chart |
| AEYE | ▲ Buy | Grant | 667 | $0 | 1/1/2026 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 15 | $4K | 12/13/2025 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 905 | — | 12/11/2025 | View on chart |
| IRMD | ▼ Sell | Open Market | 3,000 | $290K | 12/9/2025 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 1,197 | — | 12/7/2025 | View on chart |
| AEYE | ▲ Buy | Open Market | 2,000 | $22K | 11/21/2025 | View on chart |
| AEYE | ▲ Buy | Open Market | 2,000 | $23K | 11/20/2025 | View on chart |
| IRMD | ▼ Sell | Open Market | 28 | $2K | 11/20/2025 | View on chart |
| IRMD | ▼ Sell | Open Market | 100 | $9K | 11/20/2025 | View on chart |
| IRMD | ▼ Sell | Open Market | 772 | $68K | 11/20/2025 | View on chart |
| IRMD | ▼ Sell | Open Market | 1,000 | $89K | 11/20/2025 | View on chart |
| IRMD | ▼ Sell | Open Market | 1,000 | $88K | 11/20/2025 | View on chart |
| IRMD | ▼ Sell | Open Market | 100 | $9K | 11/20/2025 | View on chart |
| AEYE | ▲ Buy | Open Market | 2,000 | $23K | 11/18/2025 | View on chart |
| AEYE | ▲ Buy | Open Market | 2,000 | $23K | 11/17/2025 | View on chart |
| AEYE | ▲ Buy | Open Market | 6,000 | $71K | 11/13/2025 | View on chart |
| AEYE | ▲ Buy | Open Market | 8,000 | $101K | 11/11/2025 | View on chart |
| OSIS | ▼ Sell | Open Market | 1,500 | $425K | 11/7/2025 | View on chart |
| AEYE | ▲ Buy | Grant | 667 | $0 | 10/1/2025 | View on chart |
| OSIS | ▲ Buy | Grant | 895 | $200K | 8/20/2025 | View on chart |
| AEYE | ▲ Buy | Open Market | 8,000 | $88K | 8/18/2025 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 144 | $34K | 8/14/2025 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 170 | $38K | 7/28/2025 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 196 | $45K | 7/8/2025 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 230 | $53K | 7/6/2025 | View on chart |
| AEYE | ▲ Buy | Grant | 667 | $0 | 7/1/2025 | View on chart |
| AEYE | ▼ Sell | Other | 1,000 | $16K | 6/20/2025 | View on chart |
| AEYE | ▼ Sell | Other | 7,600 | $114K | 6/20/2025 | View on chart |
| AEYE | ▼ Sell | Other | 5,400 | $81K | 6/13/2025 | View on chart |
| AEYE | ▼ Sell | Other | 1,000 | $15K | 6/12/2025 | View on chart |
| AEYE | ▲ Buy | Grant | 5,667 | $0 | 5/23/2025 | View on chart |
| AEYE | ▲ Buy | Grant | 667 | $0 | 4/1/2025 | View on chart |
| AEYE | ▼ Sell | Other | 1,800 | $27K | 3/21/2025 | View on chart |
| AEYE | ▲ Buy | Open Market | 11,200 | $168K | 3/19/2025 | View on chart |
| AEYE | ▲ Buy | Open Market | 2,100 | $37K | 3/19/2025 | View on chart |
| AEYE | ▼ Sell | Other | 3,900 | $68K | 3/14/2025 | View on chart |
| AEYE | ▲ Buy | Grant | 215 | $0 | 3/3/2025 | View on chart |
| AEYE | ▲ Buy | Grant | 1,270 | $0 | 3/3/2025 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 15 | $3K | 12/13/2024 | View on chart |
| OSIS | ▼ Sell | Open Market | 2,000 | $365K | 12/10/2024 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 1,751 | — | 12/7/2024 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 1,196 | — | 12/7/2024 | View on chart |
| OSIS | ▲ Buy | Grant | 1,439 | $200K | 8/14/2024 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 170 | $26K | 7/28/2024 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 476 | $66K | 7/8/2024 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 231 | $32K | 7/6/2024 | View on chart |
| OSIS | ▼ Sell | Open Market | 5,785 | $775K | 5/8/2024 | View on chart |
| OSIS | ▼ Sell | Open Market | 4,215 | $566K | 5/8/2024 | View on chart |
| IRMD | ▲ Buy | Grant | 4,277 | $42K | 12/14/2023 | View on chart |
| IRMD | ▼ Sell | Open Market | 4,277 | $191K | 12/14/2023 | View on chart |
| IRMD | ▲ Buy | Grant | 5,000 | $49K | 12/13/2023 | View on chart |
| IRMD | ▼ Sell | Open Market | 5,000 | $214K | 12/13/2023 | View on chart |
| IRMD | ▲ Buy | Grant | 219 | $2K | 12/13/2023 | View on chart |
| IRMD | ▼ Sell | Open Market | 219 | $10K | 12/13/2023 | View on chart |
| IRMD | ▼ Sell | Open Market | 468 | $20K | 12/12/2023 | View on chart |
| IRMD | ▼ Sell | Open Market | 504 | $22K | 12/12/2023 | View on chart |
| IRMD | ▲ Buy | Grant | 504 | $5K | 12/12/2023 | View on chart |
| IRMD | ▲ Buy | Grant | 468 | $3K | 12/12/2023 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 1,036 | — | 12/7/2023 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 1,750 | — | 12/7/2023 | View on chart |
| IRMD | ▲ Buy | Grant | 4,273 | $30K | 12/4/2023 | View on chart |
| IRMD | ▼ Sell | Open Market | 4,273 | $182K | 12/4/2023 | View on chart |
| IRMD | ▲ Buy | Grant | 5,259 | $37K | 12/1/2023 | View on chart |
| IRMD | ▼ Sell | Open Market | 5,259 | $228K | 12/1/2023 | View on chart |
| OSIS | ▲ Buy | Grant | 1,700 | $200K | 7/28/2023 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 476 | $54K | 7/10/2023 | View on chart |
| OSIS | ▼ Sell | Tax Withholding | 230 | $27K | 7/6/2023 | View on chart |
| IRMD | ▲ Buy | Grant | 2,000 | $71K | 2/9/2023 | View on chart |
| OSIS | ▲ Buy | Grant | 148 | $13K | 12/13/2022 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 2,037 | $58K | 12/7/2022 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 1,035 | $30K | 12/7/2022 | View on chart |
| IRMD | ▲ Buy | Grant | 5,000 | $143K | 12/7/2022 | View on chart |
| IRMD | ▲ Buy | Grant | 5,000 | $143K | 12/6/2022 | View on chart |
| OSIS | ▲ Buy | Grant | 2,302 | $0 | 7/6/2022 | View on chart |
| IRMD | ▼ Sell | Open Market | 9,441 | $474K | 2/15/2022 | View on chart |
| IRMD | ▲ Buy | Grant | 9,441 | $14K | 2/15/2022 | View on chart |
| IRMD | ▼ Sell | Open Market | 559 | $27K | 12/8/2021 | View on chart |
| IRMD | ▲ Buy | Grant | 559 | $827 | 12/8/2021 | View on chart |
| IRMD | ▲ Buy | Option Exercise | 4,222 | — | 12/7/2021 | View on chart |
| IRMD | ▼ Sell | Open Market | 18,743 | $882K | 12/7/2021 | View on chart |
| IRMD | ▲ Buy | Grant | 18,743 | $28K | 12/7/2021 | View on chart |
| IRMD | ▲ Buy | Grant | 1,257 | $2K | 11/30/2021 | View on chart |
| IRMD | ▼ Sell | Open Market | 1,257 | $58K | 11/30/2021 | View on chart |
| IRMD | ▲ Buy | Grant | 12,176 | $18K | 11/29/2021 | View on chart |
| IRMD | ▼ Sell | Open Market | 12,176 | $561K | 11/29/2021 | View on chart |
| IRMD | ▼ Sell | Open Market | 4,332 | $191K | 11/26/2021 | View on chart |
| IRMD | ▲ Buy | Grant | 4,332 | $6K | 11/26/2021 | View on chart |
| IRMD | ▲ Buy | Grant | 37,454 | $55K | 11/24/2021 | View on chart |
| IRMD | ▼ Sell | Open Market | 37,454 | $1.6M | 11/24/2021 | View on chart |
| IRMD | ▲ Buy | Grant | 6,038 | $9K | 11/23/2021 | View on chart |
| IRMD | ▼ Sell | Open Market | 6,038 | $249K | 11/23/2021 | View on chart |
| IRMD | ▲ Buy | Grant | 1,234 | $2K | 11/9/2021 | View on chart |
| IRMD | ▼ Sell | Open Market | 1,234 | $47K | 11/9/2021 | View on chart |
| IRMD | ▲ Buy | Grant | 9,479 | $14K | 11/8/2021 | View on chart |
| IRMD | ▼ Sell | Open Market | 9,479 | $369K | 11/8/2021 | View on chart |
| IRMD | ▲ Buy | Grant | 5,501 | $8K | 11/5/2021 | View on chart |
| IRMD | ▼ Sell | Open Market | 5,501 | $210K | 11/5/2021 | View on chart |
| IRMD | ▲ Buy | Grant | 12,285 | $18K | 11/4/2021 | View on chart |
| IRMD | ▼ Sell | Open Market | 12,285 | $472K | 11/4/2021 | View on chart |
| IRMD | ▼ Sell | Open Market | 16,735 | $636K | 11/3/2021 | View on chart |
| IRMD | ▲ Buy | Grant | 16,735 | $25K | 11/3/2021 | View on chart |
| IRMD | ▼ Sell | Open Market | 4,766 | $181K | 11/2/2021 | View on chart |
| IRMD | ▲ Buy | Grant | 4,766 | $7K | 11/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
AudioEye Reports AI Task Drop on Inaccessible Sites
AudioEye released a study indicating that AI agents fail up to 68% of tasks on inaccessible websites. This research highlights the company's focus on digital accessibility for automated systems. The stock recently declined more than the broader market, trading near its support level.
AudioEye Reports AI Task Drop on Inaccessible Sites. AudioEye released a study indicating that AI agents fail up to 68% of tasks on inaccessible websites. This research highlights the company's focus on digital accessibility for automated systems. The stock recently declined more than the broader market, trading near its support level.